In this talk from the 2020 Advancing Excellence in Sexual and Gender Minority Health conference, Dr. Ken Mayer discusses the epidemiology of syphilis, chlamydia, gonorrhea, and other STIs among LGBTQIA+ populations, summarizes optimal STI screening strategies, and outlines approaches to integrating STI control in primary care.
Learning Resources — HIV/STI Treatment and Prevention
HIV Treatment and Prevention for Sexual and Gender Minority Patients (2020)
In this talk from the 2020 Advancing Excellence in Sexual and Gender Minority Health conference, Dr. Ken Mayer describes drivers for HIV/STI risk in LGBTQIA+ people, highlights current data around infections in the U.S., and provides recommendations and resources on how to prevent HIV/STI infection.
- Filed under
- HIV/STI Treatment and Prevention
Taking an Affirming Sexual History (2020)
In this talk from the 2020 Advancing Excellence in Sexual and Gender Minority Health conference, Julie Thompson describes barriers to care experienced by LGBTQIA+ communities, provides recommendations for talking about sex and bodies with cultural humility, and outlines a trauma-informed approach to care.
Addressing HIV and Sexually Transmitted Infections among LGBTQ People: A Primer for Health Centers
Some lesbian, gay, bisexual, transgender, and queer (LGBTQ) people face an increased risk for HIV and sexually transmitted infections (STIs). The increased risk of HV and STIs in these populations stems from both social and biological factors.Health center clinicians can help address HIV and STIs among LGBTQ people by screening appropriately based on a comprehensive sexual history, providing culturally appropriate safer sex counseling, and offering biomedical prevention strategies, such as vaccinations and pre-exposure prophylaxis for HV (PrEP).
- Filed under
- HIV/STI Treatment and Prevention
Pre-and-Post Exposure Prophylaxis
In this series of videos, Dr. Kevin Ard will discuss various aspects of PrEP and PEP.
This video course is not currently eligible for CME credit.
Providing Trauma-Informed Care at Health Centers for HIV-Positive Men Who Have Sex with Men
This brief offers health centers an introduction to providing trauma-informed care for HIV-positive men who have sex with men (MSM). The overall aims are to help health center staff understand the disproportionate prevalence of trauma and stress-related disorders among HIV-positive MSM, recognize the relationship of trauma to overall health and decreased engagement in primary care among HIV-positive MSM. This brief will also outline the promising practices in trauma-informed care to improve engagement of HIV-positive MSM in behavioral health and primary care.
HIV Prevention in the South: Reducing Stigma, Increasing Access
The HIV epidemic disproportionately affects the Southern U.S., where 51% of new HIV diagnoses occurred in 2013. Despite substantial progress along the continuum of care, HIV remains a major health concern in the South, particularly for young, Black gay and bisexual men, other men who have sex men (MSM), and transgender women. Our new publication “HIV Prevention in the South: Reducing Stigma, Increasing Access” presents four strategic elements for preventing the further spread of HIV among vulnerable populations in the South, and suggests a more hopeful future for reducing the HIV epidemic.
Transgender Women and Pre-exposure Prophylaxis for HIV Prevention: What We Know and What We Still Need to Know
The National Center for Innovation in HIV Care
Transgender women are at elevated risk of becoming infected with HIV. Pre-exposure prophylaxis for HIV prevention (PrEP) is effective in reducing the risk of HIV infection among men who have sex with men (MSM), heterosexual men and women, and people who inject drugs (PWID). While transgender women have been included in some clinical trials of PrEP, no study has shown PrEP to be effective in reducing transgender women’s HIV risk.
Protecting Yourself from HIV through Pre-Exposure Prophylaxis (PrEP): What You Need to Know
The Food & Drug Administration (FDA) recently approved the use of an HIV treatment medication for HIV-negative people at high risk of getting HIV through sexual exposure. Known as “pre-exposure prophylaxis”—or PrEP—this medication is a once-a-day pill to be used in combination with condoms and other safer sex behavioral strategies to reduce risk. Protecting Yourself from HIV through PrEP informs consumers about PrEP and how it works, as well as other ways they can work with their health care providers to protect themselves against HIV.
Emerging Clinical Issue: Hepatitis C Infection in HIV-Infected Men Who Have Sex with Men
Approximately 3.2 million individuals in the United States are infected with chronic hepatitis C (HCV) infection. While injection drug use is the most common mode of transmission, growing evidence indicates that the virus is also being spread through sexual contact, particularly among HIV-infected men who have sex with men (MSM). In this clinical brief, we review what is known about the epidemiology of HCV among HIV-infected MSM, as well as current screening, treatment, and prevention recommendations for HCV.
- Filed under
- HIV/STI Treatment and Prevention
